Skip to Content

How does Aimovig work to prevent migraine?

Answers (1)

Official Answer by Drugs.com 19 Jun 2018
Aimovig (erenumab-aooe) works to help prevent chronic migraine headaches by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is involved in migraine attacks and rises during an attack. The calcitonin gene-related peptide (CGRP) receptor antagonists are a new class of drugs for migraine. Aimovig, from Amgen, is also the first fully human monoclonal antibody for migraine prevention. This treatment for adults is given once-a-month by subcutaneous (under the skin) self-injections with an auto-injector type pen or a single-dose prefilled syringe.
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by Drugs.com

What are the brands of sumatriptan?

Updated 19 days ago 1 answerFAQ by Drugs.com

What is botulinum toxin used to treat?

Updated 10 days ago 1 answerFAQ by Drugs.com